Page last updated: 2024-08-22

galactosamine and resveratrol

galactosamine has been researched along with resveratrol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Farghali, H; Kemelo, MK; Kutinová Canová, N; Wojnarová, L	1
Farghali, H; Kgalalelo Kemelo, M; Kutinová Canová, N; Wojnarová, L	1
Li, S; Lin, H; Siu, FY; Ye, S	1

Reviews

1 review(s) available for galactosamine and resveratrol

Article	Year
In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs. Physiological research, 2016, 12-21, Volume: 65, Issue:Suppl 4 Topics: Animals; Biomedical Research; Disease Models, Animal; Down-Regulation; Drug Discovery; Galactosamine; Humans; Lipopolysaccharides; Liver Failure, Acute; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes	2016

Article

Year

In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs.

Physiological research, 2016, 12-21, Volume: 65, Issue:Suppl 4

Topics: Animals; Biomedical Research; Disease Models, Animal; Down-Regulation; Drug Discovery; Galactosamine; Humans; Lipopolysaccharides; Liver Failure, Acute; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes

2016

Other Studies

2 other study(ies) available for galactosamine and resveratrol

Article	Year
D-galactosamine/lipopolysaccharide-induced hepatotoxicity downregulates sirtuin 1 in rat liver: role of sirtuin 1 modulation in hepatoprotection. Physiological research, 2014, Volume: 63, Issue:5 Topics: Animals; Antioxidants; Carbazoles; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Galactosamine; Lipid Peroxidation; Lipopolysaccharides; Liver; Male; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes	2014
Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity. International journal of nanomedicine, 2018, Volume: 13 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Biological Availability; Caco-2 Cells; Drug Liberation; Endocytosis; Galactosamine; Humans; Inflammation; Intestinal Absorption; Intestinal Mucosa; Lactic Acid; Male; Nanoparticles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Resveratrol; Solubility; Stilbenes	2018

Article

Year

D-galactosamine/lipopolysaccharide-induced hepatotoxicity downregulates sirtuin 1 in rat liver: role of sirtuin 1 modulation in hepatoprotection.

Physiological research, 2014, Volume: 63, Issue:5

Topics: Animals; Antioxidants; Carbazoles; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Galactosamine; Lipid Peroxidation; Lipopolysaccharides; Liver; Male; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes

2014

Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.

International journal of nanomedicine, 2018, Volume: 13

Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Biological Availability; Caco-2 Cells; Drug Liberation; Endocytosis; Galactosamine; Humans; Inflammation; Intestinal Absorption; Intestinal Mucosa; Lactic Acid; Male; Nanoparticles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Resveratrol; Solubility; Stilbenes

2018